MGC Pharmaceuticals Limited
MGCLF · OTC
12/30/2023 | 6/30/2023 | 12/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -17.3% | -72.8% | 22.9% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -97.1% | -22.3% | 40.3% | 51.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -996.2% | -1,314.4% | -405.8% | -348.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,180.2% | -1,371.3% | -408.6% | -596% |
| EPS Diluted | -0.003 | -3.27 | -3.8 | -4.73 |
| % Growth | 99.9% | 13.9% | 19.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |